Yung Shin Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for YUNG SHIN PHARM, and what generic and branded alternatives to YUNG SHIN PHARM drugs are available?
YUNG SHIN PHARM has fifteen approved drugs.
Drugs and US Patents for Yung Shin Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Yung Shin Pharm | CEFACLOR | cefaclor | CAPSULE;ORAL | 065146-002 | Jan 22, 2004 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Yung Shin Pharm | GRANISETRON HYDROCHLORIDE | granisetron hydrochloride | INJECTABLE;INJECTION | 202648-002 | Jun 29, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Yung Shin Pharm | AZITHROMYCIN | azithromycin | TABLET;ORAL | 211318-001 | Mar 17, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.